Darwin Global Management, Ltd.
Q1 2026 13F Holdings
- Locationst. helier, Y9
- Num holdings
6
- Value ($000)
$3,770,701
- Date Filed 05/15/2026
- Form type13F-HR
- CIK 0001839209
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
INSMED INC | COM PAR $.01 | 457669307 | $2.58B | 68 % | 16,805,184 | ||
BELITE BIO INC | SPONSORED ADS | 07782B104 | $456.1M | 12 % | 3,057,412 | ||
ABIVAX SA | SPONSORED ADS | 00370M103 | $352.07M | 9 % | 3,468,657 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | $204.98M | 5 % | 2,211,018 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | $179.52M | 5 % | 6,797,300 | ||
DIANTHUS THERAPEUTICS INC | COM | 252828108 | $1.46M | 0 % | 17,357 |
Rows Per Page
10
- 10
- 50
- 100